{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihr5iseo7vomgybabje3t564qsfn7ziwnmucc36oeqoxunhdgsvla",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mmsdqjnikgk2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiccbk6o6o4wfprdzlmqdeim4gso7gfcaqpxqlpqrnifgsi6a3lnhy"
    },
    "mimeType": "image/webp",
    "size": 138222
  },
  "path": "/releases/2026/05/260525000504.htm",
  "publishedAt": "2026-05-26T00:56:55.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene. The compounds target cPLA2, an enzyme that seems to fuel harmful inflammation while also being important for normal brain activity.",
  "title": "USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down"
}